Cargando…
Can a cyclooxygenase inhibitor be an option for treatment of ovarian hyperstimulation syndrome?
PURPOSE: This study aimed to investigate the role of a cyclooxygenase inhibitor in ovarian hyperstimulation syndrome (OHSS) treatment and compare it with cabergoline. MATERIALS AND METHODS: A total of 32 immature female Wistar albino rats were randomly divided into four groups, with each group consi...
Autor principal: | Çilgin, Hasan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454993/ https://www.ncbi.nlm.nih.gov/pubmed/31040646 http://dx.doi.org/10.2147/DDDT.S188583 |
Ejemplares similares
-
Ovarian hyperstimulation syndrome
por: Kumar, Pratap, et al.
Publicado: (2011) -
Immunoglobulin Treatment in Severe Ovarian Hyperstimulation Syndrome
por: Gómez, Gemma Grau, et al.
Publicado: (2019) -
Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor
por: Tahermanesh, Kobra, et al.
Publicado: (2022) -
Early onset ovarian hyperstimulation syndrome despite use of segmentation approach and ovarian hyperstimulation syndrome prophylaxis
por: Mahajan, Nalini, et al.
Publicado: (2015) -
Ovarian Hyperstimulation Syndrome, the Master of Disguise?
por: Ironside, Emily Charlotte, et al.
Publicado: (2015)